Fig. 8From: Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancersEffects of CDKN2C in identifying pan-cancers and the correlation between CDKN2C expression and immune microenvironment. Panels A, B: Receiver operating characteristic curves (panel A) and a summary receiver operating characteristic curve (panel B) for identifying cancers from non-cancers based on CDKN2C expression; AUC, area under the receiver-operating characteristic curve. Panels C–F: The associations of CDKN2C expression with tumor mutation burden (TMB), microsatellite instability (MSI), homologous recombination deficiency (HRD), and immune infiltration levelsBack to article page